DNA X
SONM
DNA X (SONM) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$4.83
- EPS estimate
- $5.40
- EPS surprise
- −189.44%
- Revenue surprise
- −52.79%
- Revenue
- $16.2M
- Revenue estimate
- $34.3M
- Reported
- Oct 31, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Oct 31, 2025 | $5.40 | −$4.83 | −189.44% | $16.2M | SEC |
| Q2 2025 | Aug 8, 2025 | $0.72 | −$14.22 | −2075.00% | $11.2M | SEC |
| Q1 2025 | May 12, 2025 | −$2.34 | $1.44 | +161.54% | $16.7M | SEC |
| Q4 2024 | Mar 31, 2025 | −$7.20 | −$81.00 | −1025.00% | $15.0M | SEC |
| Q3 2024 | Nov 13, 2024 | −$11.88 | −$9.36 | +21.21% | $15.0M | SEC |
| Q2 2024 | Aug 9, 2024 | −$9.72 | −$25.38 | −161.11% | $11.5M | SEC |
| Q1 2024 | May 14, 2024 | −$5.40 | −$12.60 | −133.33% | $16.8M | SEC |
| Q4 2023 | Mar 27, 2024 | $1.80 | −$5.40 | −400.00% | $13.4M | SEC |
| Q3 2023 | Nov 14, 2023 | $0.00 | $1.80 | +0.00% | $27.6M | SEC |
| Q3 2022 | Nov 14, 2022 | −$36.00 | −$7.20 | +80.00% | $20.5M | — |
| Q1 2022 | May 10, 2022 | −$90.00 | −$68.40 | +24.00% | $13.3M | SEC |
| Q3 2021 | Nov 12, 2021 | −$108.00 | −$235.80 | −118.33% | $14.4M | SEC |
| Q2 2021 | Aug 16, 2021 | −$180.00 | −$180.00 | +0.00% | $12.0M | SEC |
| Q1 2021 | May 11, 2021 | −$180.00 | −$252.00 | −40.00% | $12.2M | SEC |
| Q4 2020 | Mar 11, 2021 | −$234.00 | −$180.00 | +23.08% | $15.8M | SEC |
| Q3 2020 | Nov 12, 2020 | −$324.00 | −$180.00 | +44.44% | $14.4M | SEC |
| Q2 2020 | Aug 12, 2020 | −$420.00 | −$396.00 | +5.71% | $21.1M | SEC |
| Q1 2020 | May 14, 2020 | −$552.00 | −$864.00 | −56.52% | $12.7M | — |
Quarterly revenue
Frequently asked questions
When did DNA X (SONM) last report earnings?
DNA X last reported on Oct 31, 2025, covering fiscal Q3 2025.
Did SONM beat earnings estimates?
No. DNA X reported EPS of −$4.83 for Q3 2025 against a $5.40 estimate — a 189.44% miss.
How much revenue did SONM report last quarter?
DNA X reported $16.2M in revenue for Q3 2025, against a consensus estimate of $34.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.